Medicines: register as a broker

AI Summary

This guidance from the Medicines and Healthcare Products Regulatory Agency (MHRA) details the registration requirements for UK-based companies acting as medicinal product brokers. Under the regulatory framework of Good Distribution Practice (GDP), a broker is defined as an entity that independently negotiates the sale or purchase of medicines without owning or physically handling the products. To gain registration, applicants must submit a request via the MHRA Submissions portal, which typically involves a 90-day processing period. During this time, the MHRA conducts background checks on staff and may perform onsite inspections to ensure compliance with GDP standards. If an inspection identifies specific issues or violations, the applicant must resolve these findings to the inspector's satisfaction before the registration is finalized and published on the UK broker register. Ongoing requirements for registered brokers include the submission of an annual compliance report by April 30th each year and notifying the agency of any changes to their registration details through a variation process. Additionally, companies must pay registration fees based on the number of sites involved and can terminate their registration by submitting a formal request before December 31st to avoid annual service charges. Professional adherence to these standards ensures the integrity of the pharmaceutical supply chain within the United Kingdom.